Royal Victoria Infirmary
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- -
- Established
- 1751-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
4
Active:1
Completed:2
Trial Phases
2 Phases
Phase 1:1
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (66.7%)Phase 1
1 (33.3%)Does CBT Improve the Perception/Impact of Cough and Breathlessness in IPF Patients
Not Applicable
- Conditions
- Idiopathic Pulmonary FibrosisCoughBreathlessness
- First Posted Date
- 2012-11-30
- Last Posted Date
- 2012-12-12
- Lead Sponsor
- Royal Victoria Infirmary
- Target Recruit Count
- 30
- Registration Number
- NCT01738711
- Locations
- 🇬🇧
Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom
Narrowband UVB for Children With Moderate to Severe Atopic Eczema
Completed
- Conditions
- Moderate to Severe Atopic Eczema
- First Posted Date
- 2012-04-03
- Last Posted Date
- 2012-04-05
- Lead Sponsor
- Royal Victoria Infirmary
- Target Recruit Count
- 58
- Registration Number
- NCT01569906
- Locations
- 🇬🇧
Royal Victoria Infirmary, Newcastle-upon-Tyne, United Kingdom
News
UK Performs First EASEE Brain Implant Surgery for Drug-Resistant Epilepsy at Newcastle Hospitals
Newcastle Hospitals successfully completed the UK's first implantation of the EASEE device, a pioneering brain stimulation implant developed by German company Precisis for treating focal epilepsy.